The latest biopharma awards press releases and news



Singapore, 7 April 2023 – IMAPAC, a leading event management company specializing in the biopharmaceutical industry, has successfully held the Asia-Pacific Bioprocessing Excellence Awards 2023 (ABEA) on March 15, 2023, at the Marina Bay Sands Expo and Convention Centre, Singapore.

The ABEA 2023 is an annual event that recognizes outstanding achievements and contributions in the bioprocessing industry, including manufacturing, research and development and supply chain management. This year’s awards ceremony attracted over 80 participants from more than 40 biopharmaceutical companies across the Asia-Pacific region.

“We are thrilled to have successfully held the ABEA 2023 in Singapore,” said Sumukhi Sreevatsan, General Manager of IMAPAC. “The awards ceremony recognizes the hard work and dedication of individuals and organizations who have made significant contributions to the bioprocessing industry. We congratulate all the winners and nominees for their achievements.”

This year’s ABEA was supported by top-tier industry leaders, including headline sponsor, Mastercontrol.

The awards ceremony consisted of 53 categories, including Best Contract Manufacturing Organization (CMO), Best Bioprocessing Supplier, Best Biomanufacturing Team, and Best Emerging Biotech Company. The winners were selected by the bioprocessing industry.

IMAPAC has announced that the Asia-Pacific Bioprocessing Excellence Awards 2024 will be held on March 13, 2024 in Singapore.

For more information on the Asia-Pacific Bioprocessing Excellence Awards 2023, visit


IMAPAC is a leading event management company specializing in the biopharmaceutical industry. With over 12 years of experience, IMAPAC has successfully organized more than 50 industry events, attracting over 15,000 participants from around the world. IMAPAC’s events are renowned for their high-quality content, prestigious speakers, and networking opportunities.


Charmaine Poh
[email protected]


The Biopharma Logistics and Supply Chain Excellence Awards (BLSA) 2023 APAC recognized outstanding achievements in biologistics across Asia at their 2023 ceremony, held alongside the 7th BioLogistics World Asia event. The awards celebrate exceptional personnel, organizations, and technologies in the industry and aim to inspire future innovators. 

The Biopharma R&D and Clinical Trials Awards (BRCTA) 2023 recognized exceptional Asian clinical trials leaders, organizations, and technologies over the past year. The awards include various categories such as Excellence Awards, Individual Awards, and Team Awards, identifying the best of the best in the industry.

WuXi Biologics has won two awards at the 2023 APAC Bioprocessing Excellence Awards (ABEA) ceremony: “Best Contract Development and Manufacturing Organization Award” and “Bioprocessing Excellence in Greater China Region Award.” This is the sixth time the company has been recognized by the ABEA. WuXi Biologics supported its clients in obtaining 123 Investigational New Drug approvals in 2022 and currently supports 17 commercial biologics and vaccines.